Coya Therapeutics (COYA) Total Liabilities (2021 - 2026)

Coya Therapeutics (COYA) has 6 years of Total Liabilities data on file, last reported at $4.3 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 14.59% year-over-year to $4.3 million; the trailing twelve-month figure through Mar 2026 stood at $4.3 million (down 14.59% YoY), and the FY2025 full-year result was $6.9 million, up 45.12% from the prior year.
• Total Liabilities fell to $4.3 million in Q1 2026, from $6.9 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $16.8 million in Q4 2022 to a low of $1.2 million in Q2 2023.
• A 5-year average of $5.1 million and a median of $4.8 million in 2024 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities jumped 1361.98% in 2022 and sank 66.49% in 2023, its largest moves.
• Tracing COYA's Total Liabilities over 5 years: stood at $16.8 million in 2022, then sank by 66.49% to $5.6 million in 2023, then dropped by 15.23% to $4.8 million in 2024, then soared by 45.12% to $6.9 million in 2025, then sank by 37.87% to $4.3 million in 2026.
• Business Quant data shows COYA's Total Liabilities at $4.3 million in Q1 2026, $6.9 million in Q4 2025, and $4.8 million in Q3 2025.